Real-World Glycemic Gaps in Pediatric T1DM Uncovered by CGM, Suggests Study
A recent study published in the Indian Journal of Pediatrics in April 2024 reveals stark discrepancies between real-world glycemic outcomes and clinical targets in pediatric patients on multiple daily insulin injections. These findings underscore an urgent need to look beyond traditional HbA1c metrics and utilize continuous glucose monitoring (CGM) to uncover hidden variability and optimize clinical management.
Traditional HbA1c testing often masks significant daily glycemic excursions. Consequently, Tandon and colleagues evaluated CGM variables and their associations with standard HbA1c and socio-economic factors in youth with Type 1 diabetes.
Therefore, in the focused observational assessment aiming to map continuous glucose profiles, researchers evaluated 92 participants with a mean age of 15.7 years and a baseline average HbA1c of 8.0%, who were seamlessly equipped with a professional continuous glucose monitoring sensor to wear for a complete 14-day duration to establish primary clinical endpoints.
Key Clinical Findings of the Study Include:
Glycemic Variability: The study revealed that a striking 92% of the monitored participants experienced high glycemic variability, reflecting a coefficient of variation greater than 36% throughout the observation period.
Time in Range: The study demonstrated that the median time in range was restricted to merely 41%, while these young participants spent an average of 41% of their day in states of hyperglycemia (above 180 mg/dl) and 14% in hypoglycemia (below 70 mg/dl).
Age Factor: The study noted that an older age at diagnosis positively correlated with higher time in range and lower time above range, albeit carrying a slightly higher risk for increased time below range.
Insulin Regimen: The study showed that the utilization of Neutral Protamine Hagedorn versus glargine basal insulin was notably associated with an increased time below range but simultaneously facilitated a decreased time above range.
HbA1c Correlations: The study established that standard HbA1c levels maintained a significant negative correlation with time in range and time below range, alongside a strong positive correlation with both time above range and overall mean glucose levels.
The results suggest significant shortfalls in achieving optimal glucose control, as patients demonstrated a median time in range of just 41%, underscoring a notably wide gap between real-world outcomes and recommended clinical glycemic targets for those relying on multiple daily insulin injections.
Thus, the study concludes that for everyday clinical practice, these insights gently indicate that routinely integrating continuous glucose monitoring can effectively identify hidden glycemic variability, serving as a highly valuable complementary tool to standard HbA1c testing for refining personalized therapeutic adjustments and improving overarching glycemic control.
While the investigation successfully highlights vital correlations between CGM metrics and HbA1c, exploring the unaddressed socio-economic variables in future research could thoughtfully provide a more comprehensive understanding of the multifaceted barriers to achieving recommended glycemic targets without counteracting these preliminary baseline findings.
Reference
Tandon, A., Bhowmik, E., Ali, Z., Tripathi, S., BK, A., Dabadghao, P., Sudhanshu, S., & Bhatia, V. (2024). Beyond HbA1c: Identifying Gaps in Glycemic Control Among Children and Young People with Type 1 Diabetes Using Continuous Glucose Monitoring. Indian Journal of Pediatrics, 91, 1238–1243.
